Carvalho A, Ellman L
Blood. 1976 Apr;47(4):669-78.
Thrombosis is one of the major complications of polycythemia vera. Seventeen patients with polycythemia vera in good hematologic control were evaluated for abnormalities of the coagulation system. Activation of the intrinsic coagulation cascade was suggested by low levels of factor XII, prekallikrein, and kallikrein inhibitors in 12 of 17 patients. The group also demonstrated a significant increase in soluble fibrin complexes using plasma gel filtration on 4% agarose. Fibrin degradation products were normal and antithrombin III levels were slightly elevated. It appears that patients with polycythemia vera have chronic activation of the coagulation system, probably initiated by activation of factor XII. No correlation between the degree of coagulation abnormalities and thromboembolic complications was evident in this group of patients.
血栓形成是真性红细胞增多症的主要并发症之一。对17例血液学控制良好的真性红细胞增多症患者的凝血系统异常情况进行了评估。17例患者中有12例因子XII、前激肽释放酶和激肽释放酶抑制剂水平较低,提示内源性凝血级联反应激活。该组患者在4%琼脂糖上进行血浆凝胶过滤时,可溶性纤维蛋白复合物也显著增加。纤维蛋白降解产物正常,抗凝血酶III水平略有升高。真性红细胞增多症患者似乎存在凝血系统的慢性激活,可能是由因子XII激活引发的。在这组患者中,凝血异常程度与血栓栓塞并发症之间没有明显相关性。